ECG Event Recorder Market size is projected to witness lucrative growth rate during the forecast period i.e., between 2024-2036. The growth of the market can be attributed to the growing prevalence of cardiovascular diseases. ECG or electrocardiogram is a device that can monitor the heart’s electrical activity. It is generally used to study the events that require long-term monitoring, especially amongst cardiac patients. The growing incidence of heart attacks and strokes, amongst other cardiac disorders, are estimated to boost the market growth. According to the data by the World Health Organization (WHO), cardiovascular disorders are responsible for 32% of all deaths worldwide. An estimated 17.9 million deaths are caused by CVDs.
Moreover, increasing adoption of technology in the healthcare sector, combined with the growing use of technical equipment are anticipated to boost the market growth. Furthermore, the increasing government investment in the healthcare sector to provide advanced healthcare facilities to the patients is further expected to propel the market growth. According to the data by the World Bank, USD 1,111.082 were spent per capita for healthcare globally, in 2018.
Growth Drivers
Challenges
The market is divided by monitor type into loop memory monitor, and symptom event monitor out of which, the symptom event monitor segment is anticipated to hold the notable share in the global ECG event recorder market over the forecast period. This can be attributed to the efficacy of symptom event monitor in predicting and avoiding any life threatening situation, such as, heart attack. Symptom event monitor specifically monitors the change in heart activity to predict symptoms of any unnatural event, which is helpful in early treatment of the patient.
Our in-depth analysis of the global ECG event recorder market includes the following segments:
By Type |
|
By Monitor Type |
|
By End-User
|
|
On the basis of geographical analysis, the global ECG event recorder market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is set to hold largest revenue share by 2036, propelled by increasing prevalence of heart-related disorders in the region. According to the data by the Center for Disease Control and Prevention (CDC), almost 659,000 people die due to heart disease every year in the United States.
September, 2021: ViiV Healthcare, collectively owned by GlaxoSmithKline plc, Pfizer Inc. and Shionogi announced approval of the U.S. Food and Drug Administration (FDA) for cabotegravir as an antiviral drug.
February, 2021: Koninklijke Philips N.V. announced the acquisition of BioTelemetry, Inc., a leading provider of remote cardiac diagnostics and monitoring, to support cardiac surgeries and treatments.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?